João Durães
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
João Durães has a total of 163 co-authors. Here are the top co-authors by number of shared publications:
- Miguel Tábuas-Pereira
Faculty of Medicine, University of Coimbra, Coimbra, Portugal
16 shared publications - Isabel Santana
University of Coimbra
11 shared publications - Inês Baldeiras
CNC—Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal
7 shared publications Isabel Santana
University of Coimbra
6 shared publications- Diana Duro
Neurology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
5 shared publications Marisa Lima
Neurology Department, Centro Hospitalar e Universitário de Coimbra, Portugal
5 shared publications
Latest Publications
- Open Access
- 1 September 2026
- Published by Wolters Kluwer Health in Neurology Open Access
- Vol. 2 (3) , e000124
Association of Alcohol Use Disorder With the Behavioral Variant of Alzheimer Disease
Background and ObjectivesVariants of Alzheimer disease (AD) particularly affect early-onset patients. Yet, most of these patients lack a family history of similar or other presentations, suggesting...
- 1 September 2026
- Published by Wolters Kluwer Health in Neurology Open Access
- Vol. 2 (3) , e000124
Open AccessAssociation of Alcohol Use Disorder With the Behavioral Variant of Alzheimer Disease
Background and ObjectivesVariants of Alzheimer disease (AD) particularly affect early-onset patients. Yet, most of these patients lack a family history of similar or other presentations, suggesting...
- 16 February 2026
- Published by SAGE Publications in Journal of Geriatric Psychiatry and Neurology
Maternal Longevity is Associated With Reduced Risk but an Earlier Onset of Alzheimer’s Disease in Offspring
Introduction: While human longevity has increased significantly over the last 2 centuries, the time spent in good physical and cognitive health has not risen proportionately. The incidence of Alzheimer’s disease (AD) increases with age, but parental longevity is often associated with better offspring health and lower AD risk. This study aimed to investigate the relationship between parental longevity and AD. Methods: We included patients with AD and cognitively healthy subjects (over 75 years), collecting family history data, namely maternal and paternal age at death. We performed a logistic regression to evaluate the association of parental longevity and AD risk and linear regression models for the association with age of onset and CSF biomarkers, adjusting for confounders. Results: We analyzed 3069 participants from a Portuguese cohort, including 893 AD patients and 2176 cognitively healthy controls. Maternal longevity was inversely associated with AD risk (OR: 0.989, 95%CI = [0.982, 0.997], P = 0.005). In AD patients, higher maternal age of death was associated with an earlier disease onset (β = −0.081, 95%CI = [−0.148, −0.013], P = 0.019). No associations were found between parental longevity and CSF biomarkers. Discussion: Maternal longevity appears protective against AD risk but is linked to an earlier onset in patients. This may indicate that protective factors for AD could become detrimental once AD is triggered. These findings highlight the complex interplay of genetic, environmental, and potentially epigenetic influences on AD.
- 16 February 2026
- Published by SAGE Publications in Journal of Geriatric Psychiatry and Neurology
Maternal Longevity is Associated With Reduced Risk but an Earlier Onset of Alzheimer’s Disease in Offspring
Introduction: While human longevity has increased significantly over the last 2 centuries, the time spent in good physical and cognitive health has not risen proportionately. The incidence of Alzheimer’s disease (AD) increases with age, but parental longevity is often associated with better offspring health and lower AD risk. This study aimed to investigate the relationship between parental longevity and AD. Methods: We included patients with AD and cognitively healthy subjects (over 75 years), collecting family history data, namely maternal and paternal age at death. We performed a logistic regression to evaluate the association of parental longevity and AD risk and linear regression models for the association with age of onset and CSF biomarkers, adjusting for confounders. Results: We analyzed 3069 participants from a Portuguese cohort, including 893 AD patients and 2176 cognitively healthy controls. Maternal longevity was inversely associated with AD risk (OR: 0.989, 95%CI = [0.982, 0.997], P = 0.005). In AD patients, higher maternal age of death was associated with an earlier disease onset (β = −0.081, 95%CI = [−0.148, −0.013], P = 0.019). No associations were found between parental longevity and CSF biomarkers. Discussion: Maternal longevity appears protective against AD risk but is linked to an earlier onset in patients. This may indicate that protective factors for AD could become detrimental once AD is triggered. These findings highlight the complex interplay of genetic, environmental, and potentially epigenetic influences on AD.
- Open Access
- 19 December 2025
- Published by Universidade do Estado do Rio de Janeiro in Revista Enfermagem UERJ
- Vol. 33, e91168
Health literacy of family caregivers of older adults with dementia due to Alzheimer’s
Objective: to evaluate, in a population sample, the level of health literacy of family Portuguese caregivers of the older adults with AD-d. Method: cross-sectional, exploratory, non-interventional, descriptive and analytical study with a non-random sample of 107 family caregivers of elderly people diagnosed with AD-d followed at the Neurology Service of the Centro Hospitalar e Universitário de Coimbra, Portugal. The research was approved by the Research Ethics Committee. The following were used: a sociodemographic questionnaire and The Alzheimer's Disease Knowledge Scale. The Mann-Whitney, Kruskal-Wallis and Spearman correlation tests were applied, at a significance level of 5%. Results: the level of knowledge of caregivers family members about Alzheimer's disease is between 63.3% and 70%. The highest score was found in the “Symptoms” domain (80.6±21.0), and the lowest in the “Being a caregiver” domain (53.8±19.3). Conclusions: the study highlighted the health literacy gap in the domain of being a caregiver, pointing to the need related to education and training in this domain.
- 19 December 2025
- Published by Universidade do Estado do Rio de Janeiro in Revista Enfermagem UERJ
- Vol. 33, e91168
Open AccessHealth literacy of family caregivers of older adults with dementia due to Alzheimer’s
Objective: to evaluate, in a population sample, the level of health literacy of family Portuguese caregivers of the older adults with AD-d. Method: cross-sectional, exploratory, non-interventional, descriptive and analytical study with a non-random sample of 107 family caregivers of elderly people diagnosed with AD-d followed at the Neurology Service of the Centro Hospitalar e Universitário de Coimbra, Portugal. The research was approved by the Research Ethics Committee. The following were used: a sociodemographic questionnaire and The Alzheimer's Disease Knowledge Scale. The Mann-Whitney, Kruskal-Wallis and Spearman correlation tests were applied, at a significance level of 5%. Results: the level of knowledge of caregivers family members about Alzheimer's disease is between 63.3% and 70%. The highest score was found in the “Symptoms” domain (80.6±21.0), and the lowest in the “Being a caregiver” domain (53.8±19.3). Conclusions: the study highlighted the health literacy gap in the domain of being a caregiver, pointing to the need related to education and training in this domain.
- 27 October 2025
- Published by Springer Nature in The Cerebellum
- Vol. 24 (6) , 1-4
Hyperactive Otolith-Ocular Reflex During Heat Tilt (Rabbit’s Eye Sign) In Anti-Ma2 Rhombencephalitis
Otolith-ocular reflex (OOR) (contralateral ocular torsion [ocular counter-roll, OCR] and skew deviation [upward deviation of the lowermost eye and/or downward deviation of the uppermost eye]), helps to maintain eye position and stabilize fixation in response to head and/or body tilt in the roll plane. While prominent in lateral-eyed animals, OOR is vestigial in humans, indicating the frontal-eyed system has evolved to inhibit this reflex. We show that OOR can be released under pathological conditions. We describe a patient with anti-Ma2-associated rhombencephalitis manifesting with hyperactive OOR, suggesting cerebellar inhibition failure over OOR brainstem machinery. A 38-year-old male presented with a 6-month history of vertical binocular diplopia exclusively elicited during head tilt to the sides, and difficulty looking down. During head tilts, there was marked OCR in both eyes and prominent hyperdeviation of the lowermost eye. There was additional supranuclear vertical saccadic palsy. Brain MRI showed mild midbrain atrophy. There were high titers of anti-Ma2 antibodies both in serum and CSF, linked to the presence of a mediastinal seminoma. Treatment with anti-inflammatory drugs was ineffective, and tumor-directed therapy was further planned. Hyperactive otolith-ocular reflex (rabbit’s eye sign) is a unique finding in humans. Its presence warrants the investigation of cerebellar/brainstem disease.
- 27 October 2025
- Published by Springer Nature in The Cerebellum
- Vol. 24 (6) , 1-4
Hyperactive Otolith-Ocular Reflex During Heat Tilt (Rabbit’s Eye Sign) In Anti-Ma2 Rhombencephalitis
Otolith-ocular reflex (OOR) (contralateral ocular torsion [ocular counter-roll, OCR] and skew deviation [upward deviation of the lowermost eye and/or downward deviation of the uppermost eye]), helps to maintain eye position and stabilize fixation in response to head and/or body tilt in the roll plane. While prominent in lateral-eyed animals, OOR is vestigial in humans, indicating the frontal-eyed system has evolved to inhibit this reflex. We show that OOR can be released under pathological conditions. We describe a patient with anti-Ma2-associated rhombencephalitis manifesting with hyperactive OOR, suggesting cerebellar inhibition failure over OOR brainstem machinery. A 38-year-old male presented with a 6-month history of vertical binocular diplopia exclusively elicited during head tilt to the sides, and difficulty looking down. During head tilts, there was marked OCR in both eyes and prominent hyperdeviation of the lowermost eye. There was additional supranuclear vertical saccadic palsy. Brain MRI showed mild midbrain atrophy. There were high titers of anti-Ma2 antibodies both in serum and CSF, linked to the presence of a mediastinal seminoma. Treatment with anti-inflammatory drugs was ineffective, and tumor-directed therapy was further planned. Hyperactive otolith-ocular reflex (rabbit’s eye sign) is a unique finding in humans. Its presence warrants the investigation of cerebellar/brainstem disease.
- Open Access
- 22 July 2025
- Published by Oxford University Press (OUP) in Brain
- Vol. 148 (11) , 4127-4142
Circadian rhythms are disrupted in patients and preclinical models of Machado-Joseph disease
Machado-Joseph disease (MJD) is caused by an abnormal CAG repeat expansion in the ATXN3 gene, leading to the expression of a mutant ataxin-3 (mutATXN3) protein. Patients with MJD exhibit a wide range of clinical symptoms, including motor incoordination. Emerging evidence highlights circadian rhythm disruptions as early indicators and potential risk factors for the progression of neurodegenerative conditions. Circadian rhythms are regulated by internal clocks, with the suprachiasmatic nucleus (SCN) acting as the master pacemaker to synchronize timing across the body’s behavioural and physiological functions. While sleep disturbances have been observed in MJD, the role of clock regulation in its pathophysiology remains largely unexplored in spinocerebellar ataxias. This study aimed to investigate circadian rhythms, characterize associated disruptions and uncover the mechanisms underlying clock dysregulation in patients and preclinical models of MJD. Circadian activity in MJD patients was assessed over 2 weeks using actigraphy, while in a YAC-MJD transgenic mouse model, circadian rhythms were examined through: (i) wheel-running experiments; (ii) telemetry-based monitoring of core body temperature; (iii) immunohistochemical analysis of the neuropeptides arginine vasopressin (AVP) and vasoactive intestinal polypeptide (VIP) in the SCN and paraventricular nucleus (PVN); and (iv) quantitative real-time PCR evaluation of clock gene expression in the cerebellum. The impact of mutATXN3 on clock mechanisms was further investigated using Bmal1/Per2-luciferase reporters. MJD patients exhibited a progressive decline in robustness of behavioural rhythms, demonstrated by negative correlations between the circadian function index, rest-activity fragmentation and sleep efficiency with MJD clinical scales. YAC-MJD mice exhibited reduced activity levels and increased behavioural fragmentation, and they required three additional days to re-entrain after a jet lag protocol compared to controls. Disrupted core body temperature rhythms were observed, including a phase advance and elevated temperature (∼1°C) at the onset of the active period. Furthermore, transgenic mice showed reduced levels of VIP and AVP in the SCN and PVN and decreased clock gene expression in the cerebellum. Lastly, we found new mechanistic evidence that wild-type ATXN3 activates the promoters of Bmal1 and Per2, whereas mutATXN3 loses the capacity to drive Per2 upon polyglutamine expansion. Overall, our findings indicate that central clock dysfunction in MJD is associated with impaired clock gene expression and disruptions in activity and temperature rhythms. This study provides the first robust evidence of circadian rhythm dysregulation and underlying mechanisms in MJD, paving the way for identifying new biomarkers and developing novel circadian-based interventions to tackle MJD and possibly other spinocerebellar ataxias.
- 22 July 2025
- Published by Oxford University Press (OUP) in Brain
- Vol. 148 (11) , 4127-4142
Open AccessCircadian rhythms are disrupted in patients and preclinical models of Machado-Joseph disease
Machado-Joseph disease (MJD) is caused by an abnormal CAG repeat expansion in the ATXN3 gene, leading to the expression of a mutant ataxin-3 (mutATXN3) protein. Patients with MJD exhibit a wide range of clinical symptoms, including motor incoordination. Emerging evidence highlights circadian rhythm disruptions as early indicators and potential risk factors for the progression of neurodegenerative conditions. Circadian rhythms are regulated by internal clocks, with the suprachiasmatic nucleus (SCN) acting as the master pacemaker to synchronize timing across the body’s behavioural and physiological functions. While sleep disturbances have been observed in MJD, the role of clock regulation in its pathophysiology remains largely unexplored in spinocerebellar ataxias. This study aimed to investigate circadian rhythms, characterize associated disruptions and uncover the mechanisms underlying clock dysregulation in patients and preclinical models of MJD. Circadian activity in MJD patients was assessed over 2 weeks using actigraphy, while in a YAC-MJD transgenic mouse model, circadian rhythms were examined through: (i) wheel-running experiments; (ii) telemetry-based monitoring of core body temperature; (iii) immunohistochemical analysis of the neuropeptides arginine vasopressin (AVP) and vasoactive intestinal polypeptide (VIP) in the SCN and paraventricular nucleus (PVN); and (iv) quantitative real-time PCR evaluation of clock gene expression in the cerebellum. The impact of mutATXN3 on clock mechanisms was further investigated using Bmal1/Per2-luciferase reporters. MJD patients exhibited a progressive decline in robustness of behavioural rhythms, demonstrated by negative correlations between the circadian function index, rest-activity fragmentation and sleep efficiency with MJD clinical scales. YAC-MJD mice exhibited reduced activity levels and increased behavioural fragmentation, and they required three additional days to re-entrain after a jet lag protocol compared to controls. Disrupted core body temperature rhythms were observed, including a phase advance and elevated temperature (∼1°C) at the onset of the active period. Furthermore, transgenic mice showed reduced levels of VIP and AVP in the SCN and PVN and decreased clock gene expression in the cerebellum. Lastly, we found new mechanistic evidence that wild-type ATXN3 activates the promoters of Bmal1 and Per2, whereas mutATXN3 loses the capacity to drive Per2 upon polyglutamine expansion. Overall, our findings indicate that central clock dysfunction in MJD is associated with impaired clock gene expression and disruptions in activity and temperature rhythms. This study provides the first robust evidence of circadian rhythm dysregulation and underlying mechanisms in MJD, paving the way for identifying new biomarkers and developing novel circadian-based interventions to tackle MJD and possibly other spinocerebellar ataxias.
- 25 February 2025
- Published by Wiley in Movement Disorders
- Vol. 40 (4) , 768-769
Dysautonomia Is Associated with Cognitive Fluctuation in Dementia with Lewy Bodies
- 25 February 2025
- Published by Wiley in Movement Disorders
- Vol. 40 (4) , 768-769
Dysautonomia Is Associated with Cognitive Fluctuation in Dementia with Lewy Bodies
- Open Access
- 20 April 2024
- Published by Sociedade Portuguesa de Neurologia in Sinapse
- Vol. 22 (4) , 173-178
X-Linked Adrenoleukodystrophy: A Heterogeneous Peroxisomal Disorder you Should Not Miss
X-linked adrenoleukodystrophy (X-ALD) is a rare peroxisomal disease caused by a mutation in gene ABCD1, impairing peroxisomal b-oxidation of very long-chain fatty acids. It has a heterogeneous clinical presentation that may difficult the diagnosis, with three main phenotypes: an Addison syndrome-like phenotype with adrenal insufficiency; a myeloneuropathic form, which progresses as a spastic paraparesis; a cerebral form with potentially extensive brain demyelination. Females can present with a phenotype resembling the myeloneuropathic form, but with a slow progression. Prompt recognition and diagnosis are essential, as allogenic hematopoietic stem cell transplantation can be offered for the cerebral form of the disease, the phenotype with the worst prognosis. We present four clinical cases of patients followed in our neurometabolic reference centre with X-ALD, highlighting different clinical presentations, diagnostic workup, management and possible clues for the diagnosis.
- 20 April 2024
- Published by Sociedade Portuguesa de Neurologia in Sinapse
- Vol. 22 (4) , 173-178
Open AccessX-Linked Adrenoleukodystrophy: A Heterogeneous Peroxisomal Disorder you Should Not Miss
X-linked adrenoleukodystrophy (X-ALD) is a rare peroxisomal disease caused by a mutation in gene ABCD1, impairing peroxisomal b-oxidation of very long-chain fatty acids. It has a heterogeneous clinical presentation that may difficult the diagnosis, with three main phenotypes: an Addison syndrome-like phenotype with adrenal insufficiency; a myeloneuropathic form, which progresses as a spastic paraparesis; a cerebral form with potentially extensive brain demyelination. Females can present with a phenotype resembling the myeloneuropathic form, but with a slow progression. Prompt recognition and diagnosis are essential, as allogenic hematopoietic stem cell transplantation can be offered for the cerebral form of the disease, the phenotype with the worst prognosis. We present four clinical cases of patients followed in our neurometabolic reference centre with X-ALD, highlighting different clinical presentations, diagnostic workup, management and possible clues for the diagnosis.
- Open Access
- 8 April 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Health literacy of family caregivers of the older adults with Dementia due to Alzheimer’s: a cross-sectional study (Preprint)
BACKGROUND Family caregiving in dementia is frequent today, with important economic, social, and human implications. In Europe, there is a trend towards keeping older adults, namely those with dementia, at home. Family caregivers face dramatic challenges, that may be mitigated by specific-training and health literacy. OBJECTIVE To assess the level of health literacy of the older adults with Dementia due to Alzheimer’s disease (AD-d) family caregivers. METHODS Cross-sectional, exploratory, non-interventional, descriptive and analytical study with a non-random sample of 107 family caregivers of elderly people diagnosed with AD-D followed at the Neurology Service of the Centro Hospitalar e Universitário de Coimbra, Portugal. The following were used: a sociodemographic questionnaire and The Alzheimer's Disease Knowledge Scale to assess the level of knowledge about AD. The description of qualitative data was done using absolute and relative frequencies, while quantitative variables were described using mean (SD) and median. The total values for each dimension and the total scale, which constitute the total number of correct answers in each dimension and in total, were converted into percentages to be comparable to each other. The distribution of each of the dimensions and the total scale was evaluated using the Shapiro-Wilk test, there were large deviations from normality, and the Mann-Whitney test was applied to compare these scores in relation to binary variables, the Kruskal test -Wallis when there were 3 or more categories and Spearman correlation to assess the relationship between these and the age of caregivers and patients. The analysis was carried out using the SPSS program, version 27, at a significance level of 5%. RESULTS Of the 107 respondents, 67.3% were female, had an average age of 60.8 (±14.0) years, 84.1% were married and 32.7% had completed high school .The majority self-assessed their health as good (46.7%), cared for their parents, spouse and/or partner (43.9%), had no prior knowledge about AD (74.8%) and sought information about AD with health professionals (72.9%). Regarding the the level of knowledge of caregivers family members about Alzheimer's disease is between 63.3% and 70%. The highest scores were found in the “Symptoms” domain (80.6±21.0) followed by “Development and progression” (79.7±15.8), and the lowest in the “Being a caregiver” domain (53.8±19.3) followed by “Risk factors” (55.6±24.1). Associations were found between: “Impact on the patient’s life” domain and prior knowledge of the disease (P=0.022); The “risk factors” were associated with length of time as caregiver (P<0.001), time since diagnosis (P=0.001), stage of diagnosis (P=0.003) and male sex (P=0.001); “Symptoms” was associated with time working as a caregiver (P=0.034) and time since diagnosis (P=0.014); “Treatment” associated with education (P=0.002), relationship with the caregiver (P=0.007); “Being a caregiver” associated with education (P=0.007), time and relationship with the caregiver (P=0.05, P=0.046), respectively; “Assessment and diagnosis” associated with education (P=0.002), gender (P =0.007) and prior knowledge of AD (P=0.041) and relationship with the caregiver (P=0.008). “Development and progression of the disease” associated with education (P=0.025), time as a caregiver (P=0.013), having prior knowledge about AD (P =0.038), seeking information from health professionals (p=0.002) and diagnosis time (P =0.002). CONCLUSIONS The results show a satisfactory level of knowledge about AD with an association between variables of interest and the ADKS scale. The study highlighted the health literacy gap in the domain of being a caregiver, pointing to the need related to education and training in this domain.
- 8 April 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessHealth literacy of family caregivers of the older adults with Dementia due to Alzheimer’s: a cross-sectional study (Preprint)
BACKGROUND Family caregiving in dementia is frequent today, with important economic, social, and human implications. In Europe, there is a trend towards keeping older adults, namely those with dementia, at home. Family caregivers face dramatic challenges, that may be mitigated by specific-training and health literacy. OBJECTIVE To assess the level of health literacy of the older adults with Dementia due to Alzheimer’s disease (AD-d) family caregivers. METHODS Cross-sectional, exploratory, non-interventional, descriptive and analytical study with a non-random sample of 107 family caregivers of elderly people diagnosed with AD-D followed at the Neurology Service of the Centro Hospitalar e Universitário de Coimbra, Portugal. The following were used: a sociodemographic questionnaire and The Alzheimer's Disease Knowledge Scale to assess the level of knowledge about AD. The description of qualitative data was done using absolute and relative frequencies, while quantitative variables were described using mean (SD) and median. The total values for each dimension and the total scale, which constitute the total number of correct answers in each dimension and in total, were converted into percentages to be comparable to each other. The distribution of each of the dimensions and the total scale was evaluated using the Shapiro-Wilk test, there were large deviations from normality, and the Mann-Whitney test was applied to compare these scores in relation to binary variables, the Kruskal test -Wallis when there were 3 or more categories and Spearman correlation to assess the relationship between these and the age of caregivers and patients. The analysis was carried out using the SPSS program, version 27, at a significance level of 5%. RESULTS Of the 107 respondents, 67.3% were female, had an average age of 60.8 (±14.0) years, 84.1% were married and 32.7% had completed high school .The majority self-assessed their health as good (46.7%), cared for their parents, spouse and/or partner (43.9%), had no prior knowledge about AD (74.8%) and sought information about AD with health professionals (72.9%). Regarding the the level of knowledge of caregivers family members about Alzheimer's disease is between 63.3% and 70%. The highest scores were found in the “Symptoms” domain (80.6±21.0) followed by “Development and progression” (79.7±15.8), and the lowest in the “Being a caregiver” domain (53.8±19.3) followed by “Risk factors” (55.6±24.1). Associations were found between: “Impact on the patient’s life” domain and prior knowledge of the disease (P=0.022); The “risk factors” were associated with length of time as caregiver (P<0.001), time since diagnosis (P=0.001), stage of diagnosis (P=0.003) and male sex (P=0.001); “Symptoms” was associated with time working as a caregiver (P=0.034) and time since diagnosis (P=0.014); “Treatment” associated with education (P=0.002), relationship with the caregiver (P=0.007); “Being a caregiver” associated with education (P=0.007), time and relationship with the caregiver (P=0.05, P=0.046), respectively; “Assessment and diagnosis” associated with education (P=0.002), gender (P =0.007) and prior knowledge of AD (P=0.041) and relationship with the caregiver (P=0.008). “Development and progression of the disease” associated with education (P=0.025), time as a caregiver (P=0.013), having prior knowledge about AD (P =0.038), seeking information from health professionals (p=0.002) and diagnosis time (P =0.002). CONCLUSIONS The results show a satisfactory level of knowledge about AD with an association between variables of interest and the ADKS scale. The study highlighted the health literacy gap in the domain of being a caregiver, pointing to the need related to education and training in this domain.
- Open Access
- 29 December 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (1) , 511
Characterization of Progranulin Gene Mutations in Portuguese Patients with Frontotemporal Dementia
In Portugal, heterozygous loss-of-function mutations in the progranulin (GRN) gene account for approximately half of the genetic mediated forms of frontotemporal dementia (FTD). GRN mutations reported thus far cause FTD through a haploinsufficiency disease mechanism. Herein, we aim to unveil the GRN mutation spectrum, investigated in 257 FTD patients and 19 family members from the central/north region of Portugal using sequencing methods. Seven different pathogenic variants were identified in 46 subjects including 40 patients (16%) and 6 relatives (32%). bvFTD was the most common clinical presentation among the GRN mutation patients, who showed a global pattern of moderate-to-severe frontotemporoparietal deficits in the neuropsychological evaluation. Interestingly, two mutations were novel (p.Thr238Profs*18, p.Leu354Profs*16), and five were previously described, although three of them only in the Portuguese population, suggesting a population-specific GRN mutational spectrum. The subjects harboring a GRN mutation showed a significant reduction in serum PGRN levels, supporting the pathogenic nature of these variants. This work broadens the mutation spectrum of GRN and the identification of the underlying GRN mutations provided an accurate genetic counselling and allowed the enrolment of subjects with GRN mutations (both asymptomatic and symptomatic) in ongoing clinical trials, which is essential to test new drugs for the disease.
- 29 December 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (1) , 511
Open AccessCharacterization of Progranulin Gene Mutations in Portuguese Patients with Frontotemporal Dementia
In Portugal, heterozygous loss-of-function mutations in the progranulin (GRN) gene account for approximately half of the genetic mediated forms of frontotemporal dementia (FTD). GRN mutations reported thus far cause FTD through a haploinsufficiency disease mechanism. Herein, we aim to unveil the GRN mutation spectrum, investigated in 257 FTD patients and 19 family members from the central/north region of Portugal using sequencing methods. Seven different pathogenic variants were identified in 46 subjects including 40 patients (16%) and 6 relatives (32%). bvFTD was the most common clinical presentation among the GRN mutation patients, who showed a global pattern of moderate-to-severe frontotemporoparietal deficits in the neuropsychological evaluation. Interestingly, two mutations were novel (p.Thr238Profs*18, p.Leu354Profs*16), and five were previously described, although three of them only in the Portuguese population, suggesting a population-specific GRN mutational spectrum. The subjects harboring a GRN mutation showed a significant reduction in serum PGRN levels, supporting the pathogenic nature of these variants. This work broadens the mutation spectrum of GRN and the identification of the underlying GRN mutations provided an accurate genetic counselling and allowed the enrolment of subjects with GRN mutations (both asymptomatic and symptomatic) in ongoing clinical trials, which is essential to test new drugs for the disease.
- Open Access
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S15)
Predicting progression of Mild Cognitive Impairment patients through four distinctive groups obtained by a dimensionality reduction algorithm
Background: The application of machine learning (ML) algorithms can help improve diagnosis and predict progression/conversion to Alzheimer’s disease (AD) at prodromal stages (Mild Cognitive Impairment – MCI)1. Due to the heterogeneity of the population at early stages and the large amount of data available, the use of unsupervised learning techniques can show distinctive patterns and help move towards personalized medicine2,3. In this work, we implemented a dimension reduction algorithm with the intent of characterizing MCI patients and develop a multistate model of progression to AD.Method: We processed 57 variables including demographic, clinical, neuroimaging, fluid biomarkers, and genetic information from a mixed population of 1041 MCI patients (544 followed at the Dementia clinic of Centro Hospitalar Universitário de Coimbra (CHUC) and 497 obtained by ADNI). Data was normalized and scaled. Afterward, we applied a dimensionality reduction algorithm (UMAP) in Python. Missing data was handled accordingly. From those with longitudinal measures (n = 351), we generated transition probability estimates by Non‐Markov Multi‐State modelling, based on the change in the status of diagnosis through time by the MMSE z‐score at each visit.Result: We obtained 4 clusters associated to: 1) increased cognitive reserve; 2) AD signature; 3) behavioral/mood alterations; and 4) mixed presentation with cardiovascular risk factors. We obtained theoretical progression rates (from faster to slower) in MCI individuals categorized in groups 2, 4, 1 and 3. After the onset of symptoms, initial decline within MCI is expected to occur in the 1st to 3rd year (in order: groups 2, 1, 4 and 3) with 60‐83% probability, and from MCI to AD from those more advanced as early as 5 (group 2) to 66 months for those in an initial phase with slower decline (group 3).Conclusion: Our results show added value for the application of ML techniques in processing data with the intent to improve the characterization and follow‐up of MCI patients. We suggest that these four groups should be targeted and considered for monitoring patient care.1. Silva‐Spínola A, et al. Biomedicines 2022; 2.Chun MY, et al. Front Aging Neurosc. 2022; 3.Tam A, et al. J Prev Alz Dis. 2022.
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S15)
Open AccessPredicting progression of Mild Cognitive Impairment patients through four distinctive groups obtained by a dimensionality reduction algorithm
Background: The application of machine learning (ML) algorithms can help improve diagnosis and predict progression/conversion to Alzheimer’s disease (AD) at prodromal stages (Mild Cognitive Impairment – MCI)1. Due to the heterogeneity of the population at early stages and the large amount of data available, the use of unsupervised learning techniques can show distinctive patterns and help move towards personalized medicine2,3. In this work, we implemented a dimension reduction algorithm with the intent of characterizing MCI patients and develop a multistate model of progression to AD.Method: We processed 57 variables including demographic, clinical, neuroimaging, fluid biomarkers, and genetic information from a mixed population of 1041 MCI patients (544 followed at the Dementia clinic of Centro Hospitalar Universitário de Coimbra (CHUC) and 497 obtained by ADNI). Data was normalized and scaled. Afterward, we applied a dimensionality reduction algorithm (UMAP) in Python. Missing data was handled accordingly. From those with longitudinal measures (n = 351), we generated transition probability estimates by Non‐Markov Multi‐State modelling, based on the change in the status of diagnosis through time by the MMSE z‐score at each visit.Result: We obtained 4 clusters associated to: 1) increased cognitive reserve; 2) AD signature; 3) behavioral/mood alterations; and 4) mixed presentation with cardiovascular risk factors. We obtained theoretical progression rates (from faster to slower) in MCI individuals categorized in groups 2, 4, 1 and 3. After the onset of symptoms, initial decline within MCI is expected to occur in the 1st to 3rd year (in order: groups 2, 1, 4 and 3) with 60‐83% probability, and from MCI to AD from those more advanced as early as 5 (group 2) to 66 months for those in an initial phase with slower decline (group 3).Conclusion: Our results show added value for the application of ML techniques in processing data with the intent to improve the characterization and follow‐up of MCI patients. We suggest that these four groups should be targeted and considered for monitoring patient care.1. Silva‐Spínola A, et al. Biomedicines 2022; 2.Chun MY, et al. Front Aging Neurosc. 2022; 3.Tam A, et al. J Prev Alz Dis. 2022.